Hospital News
Return to Heart Transplant Surgery Overview
More on Heart Transplant Surgery
- NewYork-Presbyterian/Columbia Announces State-of-the-Art, Vivian and Seymour Milstein Family Heart Center in Washington Heights
- NewYork-Presbyterian/Columbia Sets U.S. Record for Number of Heart Transplants in One Year
- "Bad" Cholesterol May Not Be the Best Predictor of Heart Disease Risk in Generally Healthy Individuals
- 9/11 Lifestyle Changes May Increase Cardiovascular Risk
- Accuracy of Gene Expression Test for Heart Transplant Patients Confirmed by Independent Clinical Data
- Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
- A NYC First: Patient Participates in Stem Cell Clinical Trial to Repair Heart Damaged by Severe Coronary Artery Disease
- Columbia Research Suggests Need to Rethink Causes of Heart Failure
- Columbia Scientists Study Advantages of Using Web to Tailor Medical Information to Patients
- Columbia University Mailman School of Public Health Receives $23 Million From NHLBI to Lead Network Evaluating Novel Interventions in Cardiac Surgery
- Columbia University Medical Center Releases Preliminary Results of Robotic Open-Heart Surgery Study
- Columbia University Medical Center Study Shows Stress Test Saves Lives of Patients With Chest Pain
- Computerized Electrocardiogram Rhythm Errors Common, NewYork-Presbyterian/Weill Cornell Study Finds
- Dean Antonio M. Gotto, Jr., Elected Fellow of American Academy of Arts and Sciences
- Diabetics Benefit Less from Anti-Hypertensive Treatment to Reduce Enlarged Heart
- Do Heart Disease and Cancer Have a Common Genetic Link?
- Electrocardiogram Helps Predict Risk for Congestive Heart Failure in Hypertensive Patients
- FDA Approves HeartMate II Mechanical Heart Pump for Heart-Failure Patients Waiting for Organ Transplantation
- FDA Approves Implanted Heart Pumps That Lengthen and Improve Lives of Terminally Ill Heart Failure Patients
- First Robot-Assisted Coronary Artery Bypass Surgery in the U.S. Performed at NewYork-Presbyterian Hospital
- For High-Blood-Pressure Patients, Preventing or Reducing Enlarged Heart Decreases Risk of Heart Failure
- Gene Test Detects Heart Transplant Rejection
- Genetic Medicine Program at Weill Cornell Receives Major Boost from The Starr Foundation
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Heart Health Inspiration & Strategies for the Whole Family
- Hollywood Comes Knocking: Dr. Mehmet Oz of NewYork-Presbyterian Hospital is Medical Expert for Denzel Washington Film John Q
- JAMA Article Looks at Data-Sharing in Clinical Trials for Heart Disease
- Keeping the Beat: NewYork-Presbyterian Offers Heart Patients New Combination Defibrillator/Pacemakers
- Larger Waistline Is Linked to Increased Risk for Heart Disease in Women
- Left Ventricular Assist Devices May Improve Heart Function and Lead to Search for New Therapies To Obviate Need for Transplants
- Lovastatin Treatment Reduces Events in Patients at Varying Degrees of Coronary Risk and Reduces Need for Invasive Procedures
- Lupus Patients at Increased Risk for Atherosclerosis, Weill Cornell Study Finds
- Morgan Stanley Children's Hospital Performs Transcatheter Pulmonary Valve Replacement
- New Intravascular Radiation Procedures Reduce Renarrowing of Coronary Arteries
- New Laser Technology Offers Promise for Heart Disease Patients
- New Methodology Gives Weill Cornell Team Insights into Psychological Value of Cardiac Stress Testing
- New Treatment May Prolong Life for Heart Transplant Patients
- NewYork-Presbyterian/Weill Cornell Physician-Scientists Present Findings at American Heart Association's Annual Conference
- NewYork-Presbyterian Hospital and Columbia University Medical Center Physician-Scientists Present Clinical Research at American Heart Association's Annual Conference
- NYC First: NewYork-Presbyterian/Columbia Cardiologists Implant Novel Stroke-Prevention Device for Heart Patients with Atrial Fibrillation
- Physician-Scientist Urges Improved Drug Regulation to Ensure Safety of Non-Heart Drugs
- Potential for Adult Stem Cells to Repair Hearts Damaged by Severe Coronary Artery Disease Investigated in Ongoing Study
- Reducing Enlarged Heart Muscle Cuts Patients' Cardiac Risk, Independent of Lowered Blood Pressure, NewYork-Presbyterian/Weill Cornell Researchers Report
- Researcher Predicts Paradigm Shift in Heart Disease Treatment
- Research Shows Cholesterol-Lowering Drug Lovastatin Reduces Risk of Heart Attack in Healthy Adults
- Weill Cornell Dean and Cardiovascular Expert Makes "Top Ten" Texas List
- Weill Cornell Physician-Scientists Win 2 Top Awards at American Heart Association Meeting
- Weill Cornell Receives $7.6 Million Federal Grant for Clinical Trials on New Ways To Change Behavior in Patients With Cardiopulmonary Disease
- Weill Cornell Researchers Identify a Likely Genetic Cause of Atherosclerosis
- Weill Cornell Scientists Reveal Action of a Histamine Receptor That May Lead to New Therapies for Heart Attacks
Research and Clinical Trials
Return to Heart Transplant Surgery Overview
More on Heart Transplant Surgery
Clinical Services
Return to Heart Transplant Surgery Overview
More on Heart Transplant Surgery
- Advanced Diagnostics
- Alcohol Septal Ablation
- Angiograms
- Angioplasty and Stenting
- Arrhythmia Control
- Artificial Heart Devices: LVAD
- Cardiac Electrophysiologic Studies and T-wave Alternans Testing
- Cardiac Magnetic Resonance Imaging (MRI)
- Cardiac Rehabilitation
- Cardiology
- Cardiothoracic Surgery
- Catheter Ablation for Cardiac Arrhythmias
- Coronary Artery Bypass Surgery (Grafting)
- Echocardiograms
- Electrocardiograms (ECGs), Stress Tests, Holter Monitor and Event/Loop Recorders
- Heart Valve Repair and Replacement
- Implantable Converter Defibrillators and Biventricular Pacing
- Intravascular / Intracoronary and Intracardiac Ultrasound
- Nuclear Imaging For Heart Disease (PET scans, MUGA scans)
- Off-pump Surgery
- Pacemakers
- Pediatric Heart Surgery
- Preventive Cardiology
- Preventive Medicine and Nutrition
- Robotic Heart Surgery
- Surgery for Adult Congenital Heart Disease
- Tilt Testing
- Transmyocardial Revascularization
- Treatment of Peripheral Arterial Disease
- Treatments for Heart Valve Disease
Heart Transplant Surgery
Patients with end-stage heart failure who do not respond to medical treatment may be candidates for heart transplants. In heart transplant surgery, a patient's diseased heart is removed and replaced with a healthy, donated human heart. NewYork-Presbyterian Hospital has a distinguished history of advancing "standards of care" and the survival rates of our patients by using innovative surgical techniques, applying our basic scientific research in immunosuppression to the clinical setting, and inventing and perfecting life-sustaining cardiac assist devices that prolong life while waiting for organ availability. Surgeons at NewYork-Presbyterian have already performed more heart transplants – over 1700 – since 1977.
Every year, heart transplant surgery remains limited to the most severe cases. This is due, in part, to a shortage of donor hearts, which must pass through a stringent screening process. Moreover, the need for donated hearts goes beyond those on the transplant waiting list. There are many patients who — because of complicating health issues or age restrictions — are not eligible to be included on the transplant waiting list, yet are in need of a transplant.
In an attempt to address these problems, the heart transplant team at NewYork-Presbyterian Hospital recently launched the Alternative Heart Transplant Program, which expands the usual criteria by which donor hearts are accepted. If, after careful assessment by our transplant team, the donor heart’s function is found to be acceptable, the program tries to match the heart to a patient who would otherwise not be eligible for transplant.
Find a Physician
Hospital News
- NewYork-Presbyterian/Columbia Announces State-of-the-Art, Vivian and Seymour Milstein Family Heart Center in Washington Heights
- NewYork-Presbyterian/Columbia Sets U.S. Record for Number of Heart Transplants in One Year
- "Bad" Cholesterol May Not Be the Best Predictor of Heart Disease Risk in Generally Healthy Individuals More
